- Home
- QIPT vs RPID Comparison
QIPT vs RPID Comparison
Compare QIPT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- RPID
- Stock Information
- Founded
- QIPT 1993
- RPID 2006
- Country
- QIPT United States
- RPID United States
- Employees
- QIPT N/A
- RPID N/A
- Industry
- QIPT
- RPID Medical Specialities
- Sector
- QIPT
- RPID Health Care
- Exchange
- QIPT Nasdaq
- RPID Nasdaq
- Market Cap
- QIPT 92.2M
- RPID 106.5M
- IPO Year
- QIPT N/A
- RPID 2021
- Fundamental
- Price
- QIPT $2.61
- RPID $3.79
- Analyst Decision
- QIPT Buy
- RPID Strong Buy
- Analyst Count
- QIPT 2
- RPID 2
- Target Price
- QIPT $3.15
- RPID $8.00
- AVG Volume (30 Days)
- QIPT 277.2K
- RPID 71.4K
- Earning Date
- QIPT 08-11-2025
- RPID 10-31-2025
- Dividend Yield
- QIPT N/A
- RPID N/A
- EPS Growth
- QIPT N/A
- RPID N/A
- EPS
- QIPT N/A
- RPID N/A
- Revenue
- QIPT $238,378,000.00
- RPID $30,289,000.00
- Revenue This Year
- QIPT N/A
- RPID $16.63
- Revenue Next Year
- QIPT $28.69
- RPID $21.98
- P/E Ratio
- QIPT N/A
- RPID N/A
- Revenue Growth
- QIPT N/A
- RPID 22.57
- 52 Week Low
- QIPT $1.35
- RPID $0.83
- 52 Week High
- QIPT $3.27
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- QIPT 51.58
- RPID 72.23
- Support Level
- QIPT $2.58
- RPID $3.11
- Resistance Level
- QIPT $2.69
- RPID $3.38
- Average True Range (ATR)
- QIPT 0.08
- RPID 0.25
- MACD
- QIPT -0.03
- RPID 0.06
- Stochastic Oscillator
- QIPT 21.05
- RPID 95.57
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.